Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Nuvation Bio (NUVB) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
SafusidenibOligodendroglioma, Grade 2 Glioma (Astrocytoma Or Oligodendroglioma) With An Idh1 Mutation, Astrocytoma Idh Mutant Grade 2, Oligodendroglioma Idh-Mutant And 1P/19Q-Codeleted, Idh-Mutant GliomasPhase IIINot Yet RecruitingSafety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant GliomaJul 09, 2026
SafusidenibGlioma, Oligodendroglioma, Idh1-Mutant Glioma, Astrocytoma Idh Mutant Grade 2, Grade 2 Idh1-Mutant Glioma, Grade 3 Idh1-Mutant Glioma, Oligodendroglioma Idh-1 Mutant And 1/P19q-Codeleted, Astrocytoma Idh Mutant Grade 3Phase IINot Yet RecruitingSafety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive DiseaseJul 09, 2026―
TaletrectinibNon-Small Cell Lung Cancer (Nsclc)Phase IIIRecruitingPhase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)Aug 18, 2025
Crizotinib, TaletrectinibNon Small Cell Lung CancerPhase IIIRecruitingA Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer PatientsAug 12, 2024―
Nuv-1511Pancreatic Cancer, Advanced Solid Tumor, Metastatic Castration-Resistant Prostate Cancer (Mcrpc), Her2-Negative Breast Cancer, Platinum-Resistant Ovarian Cancer (Proc)phase1AndPhase2Active Not RecruitingSafety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid TumorsFeb 12, 2024―
Multiple Administration Of Omeprazole Single Administration Of Ab-106Pharmacokinetic StudyPhase ICompletedStudy the Effect of Omeprazole on AB-106 PharmacokineticsOct 26, 2022―
SafusidenibGlioma, Astrocytoma, Grade Iv, Idh1-Mutant Glioma, Astrocytoma, Idh-Mutant, Grade 3, Astrocytoma, Idh-Mutant, Grade 4Phase IIIRecruitingSIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)Mar 13, 2022
Olaparib, Enzalutamide, Nuv-868Prostate Neoplasm, Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer, Advanced Solid Tumor, Triple Negative Breast Neoplasms, Triple Negative Breast Cancer, Cancer Of The Ovary, Triple-Negative Breast Cancer, Pancreas Cancer, Prostatic Cancer, Cancer Of Prostate, Cancer Of The Prostate, Castrate Resistant Prostate Cancer, Castration Resistant Prostatic Cancer, Castration Resistant Prostatic Neoplasms, Breast Carcinoma, Cancer Of Pancreas, Cancer Of The Breast, Cancer Of Breast, Breast Tumor, Ovary Cancer, Cancer Of Ovary, Ovary Neoplasm, Cancer Of The Pancreas, Pancreas NeoplasmPhase ITerminatedNUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsJan 28, 2022―
Enzalutamide, Nuv-422Prostate Neoplasm, Prostate Cancer, Prostatic Cancer, Cancer Of Prostate, Cancer Of The Prostate, Castrate Resistant Prostate Cancer, Castration Resistant Prostatic Cancer, Castration Resistant Prostatic Neoplasmsphase1AndPhase2WithdrawnStudy of NUV-422 in Combination With Enzalutamide in Patients With mCRPCDec 22, 2021―
Fulvestrant, Nuv-422Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Breast Carcinoma, Cancer Of The Breast, Cancer Of Breast, Malignant Tumor Of Breast, Breast Tumorphase1AndPhase2WithdrawnStudy of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBCDec 22, 2021―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Nuvation Bio Inc (NUVB) have in its pipeline
Nuvation Bio NUVB is currently developing the following drugs: Safusidenib, Taletrectinib, Crizotinib, Taletrectinib, Nuv-1511, Multiple Administration Of Omeprazole Single Administration Of Ab-106, Olaparib, Enzalutamide, Nuv-868, Enzalutamide, Nuv-422, Fulvestrant, Nuv-422, Ab-106, Digoxin, Ab-106, Itraconazole, Ab-106, Rifampicin, Nuv-422, Ab-106, Ds-6051B, Ds6051b. These drug candidates are in various stages of clinical development as the company works toward FDA approval.